================================================================================
SEC 1745 (3-98) Potential persons who are to respond to the collection of
information contained in this form are not required to respond
unless the form displays a currently valid OMB control number.
================================================================================
OMB APPROVAL
-------------------------------------
OMB Number 3235-0145
Expire October 31, 2002
Estimated average burden
hours per response..............14.90
-------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 10 )*
Merit Medical Systems, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, No Par Value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
589889-10-4
-------------
(CUSIP Number)
December 31, 2000
-----------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
1
CUSIP No. 589889-10-4
- --------------------------------------------------------------------------------
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Fred P. Lampropoulos
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC Use Only
-----------------------------------------------------------
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization United States
----------------
- --------------------------------------------------------------------------------
Number of 5. Sole Voting Power 834,248.493
Shares Bene-
ficially 6. Shared Voting Power None
Owned by Each
Reporting 7. Sole Dispositive Power 834,248.493
Person With:
8. Shared Dispositive Power None
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 834,248.493
------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) [ ]
11. Percent of Class Represented by Amount in Row (9) 10.3%
---------
12. Type of Reporting Person (See Instructions) IN
-----
2
CUSIP No. 589889-10-4
- --------------------------------------------------------------------------------
Item 1.
(a) Name of Issuer: Merit Medical Systems, Inc. (the "Company")
(b) Address of Principal Executive Offices:
1600 West Merit Parkway, South Jordan, UT 84095
Item 2.
(a) Name of Person Filing:
Fred P. Lampropoulos (the"Reporting Person")
(b) Address of Principal Business Office, if none, Residence:
1600 West Merit Parkway, South Jordan, UT 84095
(c) Citizenship: United States
(d) Title of Class of Securities:
Common Stock, No Par Value (the "Commonn Stock")
(e) CUSIP Number: 589889-10-4
Item 3.
This statement is not filed pursuant to Sections 240.13d-1(b) or
240.13d-2(b) or (c).
Item 4. Ownership
(a) Amount Beneficially Owned: As of December 31, 2000, the Reporting
Person was the beneficial owner of 834,248.493 shares of the Common
Stock, which included 16,547.493 shares owned by the Reporting
Person pursuant to the Company's 401(k) Plan, based upon the most
recent plan statement timely distributed, and 332,500 shares that
the Reporting Person had the right to acquire pursuant to options
that were exercisable as of December 31, 2000 or exercisable within
the sixty (60) day period following December 31, 2000.
(b) Percent of Class: 10.3%
(c) Number of shares as to which the Reporting Person has:
(i) Sole power to vote or to direct the vote: 834,248.493 shares
of the Common Stock
(ii) Shared power to vote or to direct the vote: None
(iii) Sole power to dispose or to direct the disposition of:
834,248.493 shares of the Common Stock
(iv) Shared power to dispose or to direct the disposition of: None
3
CUSIP No. 589889-10-4
- --------------------------------------------------------------------------------
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [ ]
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reporting on By the Parent Holding Company
Not applicable.
Item 8. Identification and Classification of Members of the Group
Not applicable
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
Not applicable.
4
CUSIP No. 589889-10-4
- --------------------------------------------------------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 12, 2001
By /s/ Fred P. Lampropoulos
- ---------------------------
Fred P. Lampropouos
5